PMC:3839092 / 9181-9660 JSONTXT

{"project":"2_test","denotations":[{"id":"24324445-23702452-41737769","span":{"begin":184,"end":185},"obj":"23702452"},{"id":"24324445-21969419-41737770","span":{"begin":187,"end":188},"obj":"21969419"},{"id":"24324445-21786117-41737771","span":{"begin":190,"end":192},"obj":"21786117"}],"text":"Anhedonia\nOur approach to quantifying anhedonia allows for clinician- and self-rated assessments to contribute equally to the anhedonia score (range 1–13). As in our previous studies (8, 9, 27), the score for each subject was computed by summing the responses to three items associated with anhedonia from the clinician-rated CDRS-R (item 2: “difficulty having fun;” scale of 1–7) and the self-rated BDI-II (items 4: “loss of pleasure” and 12: “loss of interest;” scales of 0–3)."}

{"project":"NEUROSES","denotations":[{"id":"T254","span":{"begin":400,"end":403},"obj":"CHEBI_53651"}],"text":"Anhedonia\nOur approach to quantifying anhedonia allows for clinician- and self-rated assessments to contribute equally to the anhedonia score (range 1–13). As in our previous studies (8, 9, 27), the score for each subject was computed by summing the responses to three items associated with anhedonia from the clinician-rated CDRS-R (item 2: “difficulty having fun;” scale of 1–7) and the self-rated BDI-II (items 4: “loss of pleasure” and 12: “loss of interest;” scales of 0–3)."}